Stockreport

TRexBio Announces Collaboration Partner Lilly Has Initiated a Phase 1 Study of TRB-051 for Autoimmune and Inflammatory Diseases [Yahoo! Finance]

Eli Lilly and Company  (LLY) 
Last eli lilly and company earnings: 4/23 06:25 am Check Earnings Report
US:NYSE Investor Relations: investor.lilly.com
PDF TRB-051 program is the first to enter the clinic under the Research Collaboration and License Agreement between TRexBio and Lilly Collaboration leveraged TRexBio's De [Read more]